◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › C › CNMD

CONMED Corporation (CNMD) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · MEDICAL DEVICES · DATA UPDATED 2026-09-15

CONMED Corporation (CNMD) operates in the MEDICAL DEVICES industry and is headquartered in Largo, United States with about 3,900 employees. Its market capitalization is roughly $1 billion. In the fiscal year ended 2025-12-31, CNMD reported $1.4B in revenue and $47M in net income.

CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures.

Interactive charts & full statements → Open the CNMD valuation workbench →

CNMD Revenue & Earnings History — Annual Income Statement

Income statement	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Revenue	$1.4B	$1.4B	$1.3B	$1.2B	$1.0B	$1.0B	$862M	$955M	$860M	$796M	$764M	$719M	$734M	$757M	$767M	$725M	$714M	$695M	$742M	$694M	$647M
Gross Profit	$752M	$725M	$733M	$676M	$571M	$568M	$460M	$525M	$469M	$431M	$408M	$382M	$398M	$406M	$406M	$375M	$365M	$337M	$382M	$349M	$313M
Gross Margin %	54.8%	52.8%	56.1%	54.3%	54.6%	56.2%	53.4%	54.9%	54.6%	54.1%	53.5%	53.1%	54.2%	53.7%	52.9%	51.7%	51.2%	48.6%	51.5%	50.3%	48.4%
Operating Income (EBIT)	$148M	$141M	$200M	$121M	$70M	$110M	$46M	$79M	$71M	$47M	$38M	$51M	$53M	$57M	$65M	$8M	$57M	$28M	$75M	$81M	($5M)
Operating Margin %	10.8%	10.3%	15.3%	9.7%	6.7%	10.9%	5.3%	8.3%	8.3%	5.9%	4.9%	7.1%	7.2%	7.5%	8.5%	1.1%	8.0%	4.1%	10.1%	11.7%	-0.7%
Net Income	$56M	$47M	$132M	$64M	($81M)	$63M	$10M	$29M	$41M	$55M	$15M	$30M	$32M	$36M	$40M	$1M	$30M	$12M	$45M	$41M	($13M)
Net Margin %	4.1%	3.4%	10.1%	5.2%	-7.7%	6.2%	1.1%	3.0%	4.8%	7.0%	1.9%	4.2%	4.4%	4.8%	5.3%	0.1%	4.2%	1.8%	6.0%	6.0%	-1.9%
EBITDA	$180M	$155M	$272M	$192M	$8M	$179M	$118M	$146M	$133M	$105M	$90M	$95M	$99M	$104M	$112M	$47M	$95M	$67M	$112M	$113M	$25M
Earnings Per Share (EPS)	$1.85	$1.51	$4.26	$2.04	$-2.68	$1.94	$0.32	$0.97	$1.41	$1.97	$0.52	$1.09	$1.16	$1.28	$1.41	$0.03	$1.05	$0.42	$1.52	$1.43	$-0.45
Shares Outstanding (M)	30M	31M	31M	32M	30M	32M	29M	29M	29M	28M	28M	28M	28M	28M	29M	29M	29M	29M	29M	29M	28M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CNMD Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Total Revenue	$343M	$317M	$373M	$339M	$343M	$319M	$346M	$317M
Gross Profit	$197M	$183M	$213M	$158M	$181M	$168M	$198M	$179M
Gross Margin %	57.5%	57.9%	57.1%	46.7%	52.6%	52.6%	57.3%	56.5%
Operating Income (EBIT)	$36M	$25M	$67M	$19M	$42M	$11M	$52M	$66M
Operating Margin %	10.6%	8.0%	17.9%	5.7%	12.2%	3.6%	15.2%	20.8%
Net Income	$23M	$14M	$17M	$3M	$21M	$6M	$34M	$49M
Net Margin %	6.7%	4.4%	4.5%	0.8%	6.2%	1.9%	9.8%	15.5%
EBITDA	$61M	$38M	$55M	$25M	$51M	$29M	$71M	$84M
Earnings Per Share (EPS)	$0.77	$0.45	$0.54	$0.09	$0.69	$0.19	$1.08	$1.57
Shares Outstanding (M)	30M	31M	31M	31M	31M	31M	31M	31M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CNMD Free Cash Flow History

Cash flow	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Cash from Operations (CFO)	$151M	$171M	$167M	$125M	$33M	$112M	$65M	$95M	$75M	$66M	$38M	$48M	$65M	$81M	$95M	$103M	$38M	$25M	$61M	$66M	$65M
Capital Expenditures (CapEx)	$16M	$20M	$13M	$19M	$22M	$15M	$13M	$20M	$17M	$13M	$15M	$15M	$15M	$18M	$22M	$22M	$15M	$21M	$36M	$21M	$22M
Free Cash Flow (FCF)	$134M	$151M	$154M	$106M	$12M	$97M	$52M	$75M	$58M	$53M	$23M	$33M	$50M	$63M	$74M	$81M	$24M	$4M	$25M	$45M	$43M
FCF Margin %	9.8%	11.0%	11.8%	8.5%	1.1%	9.6%	6.0%	7.9%	6.8%	6.6%	3.1%	4.6%	6.8%	8.3%	9.6%	11.2%	3.3%	0.5%	3.4%	6.5%	6.6%
Dividends Paid	$12M	$25M	$25M	$25M	$24M	$23M	$23M	$23M	$22M	$22M	$22M	$22M	$22M	$17M	$13M	$58M	$12M	—	—	—	—

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CNMD Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Cash from Operations (CFO)	$37M	$13M	$46M	$54M	$29M	$42M	$43M	$51M
Capital Expenditures (CapEx)	$3M	$3M	$5M	$5M	$6M	$4M	$4M	$3M
Free Cash Flow (FCF)	$34M	$11M	$41M	$48M	$23M	$38M	$39M	$48M
FCF Margin %	10.0%	3.3%	11.0%	14.3%	6.8%	11.8%	11.4%	15.1%
Dividends Paid	$0M	$0M	$6M	$6M	$6M	$6M	$6M	$6M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CNMD Balance Sheet History

Balance sheet	2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Assets	$2.3B	$2.3B	$2.3B	$2.3B	$2.3B	$1.8B	$1.8B	$1.8B	$1.4B	$1.4B	$1.3B	$1.1B	$1.1B	$1.1B	$1.1B	$936M	$986M	$958M	$932M	$894M	$862M
Cash & Cash Equivalents	$37M	$41M	$24M	$24M	$29M	$21M	$27M	$26M	$18M	$33M	$27M	$73M	$66M	$54M	$24M	$26M	$12M	$9M	$12M	$12M	$4M
Total Liabilities	$1.3B	$1.3B	$1.3B	$1.5B	$1.6B	$981M	$1.0B	$1.1B	$707M	$727M	$748M	$528M	$517M	$484M	$477M	$363M	$399M	$381M	$400M	$389M	$421M
Total Debt (Short + Long-Term)	$834M	$835M	$906M	$981M	$1.1B	$685M	$761M	$776M	$457M	$486M	$498M	$271M	$241M	$216M	$162M	$144M	$196M	$184M	$199M	$223M	$268M
Total Shareholders' Equity	$1.0B	$1.0B	$963M	$834M	$746M	$785M	$709M	$710M	$662M	$631M	$581M	$585M	$581M	$606M	$607M	$573M	$587M	$577M	$532M	$505M	$440M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive CNMD viewer.

Other Companies in MEDICAL DEVICES

BFLY · Butterfly Network Inc — $2 billion
ESTA · Establishment Labs Holdings Inc — $2 billion
NVCR · Novocure Ltd — $2 billion
ATEC · Alphatec Holdings Inc — $2 billion
IART · Integra LifeSciences Holdings — $1 billion
TNDM · Tandem Diabetes Care Inc — $1 billion
AORT · Artivion Inc — $1 billion
PRCT · Procept Biorobotics Corp — $1 billion

← CNM All “C” companies CNNE →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.